• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma.

作者信息

Kudo Masatoshi

机构信息

Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.

出版信息

Liver Cancer. 2021 Dec 8;11(1):1-8. doi: 10.1159/000521374. eCollection 2022 Jan.

DOI:10.1159/000521374
PMID:35222503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8820154/
Abstract
摘要

相似文献

1
Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma.新开发的改良ALBI分级对肝细胞癌显示出更好的预后和预测价值。
Liver Cancer. 2021 Dec 8;11(1):1-8. doi: 10.1159/000521374. eCollection 2022 Jan.
2
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis.白蛋白-胆红素分级在经动脉化疗栓塞治疗肝细胞癌患者中的预后价值：系统评价和荟萃分析。
J Gastrointest Cancer. 2023 Jun;54(2):420-432. doi: 10.1007/s12029-022-00832-0. Epub 2022 May 30.
3
Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort.白蛋白-胆红素分级在肝细胞癌患者中的预后价值：在中国队列中的验证
Hepatol Res. 2017 Jul;47(8):731-741. doi: 10.1111/hepr.12796. Epub 2016 Nov 3.
4
Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.结合白蛋白-胆红素分级的改良CLIP评分在接受经动脉化疗栓塞治疗的HBV相关肝细胞癌患者中保留了预后价值。
J Cancer. 2018 Jun 14;9(13):2380-2388. doi: 10.7150/jca.22925. eCollection 2018.
5
Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases.白蛋白-胆红素分级在肝细胞癌及其他肝脏疾病患者中的预后价值。
Ann Transl Med. 2020 Apr;8(8):553. doi: 10.21037/atm.2020.02.116.
6
Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization.改良 Child-pugh（MCP）、白蛋白-胆红素（ALBI）和 Child-pugh（CP）评分在预测经导管动脉化疗栓塞治疗的肝细胞癌患者生存中的比较。
Bull Cancer. 2021 Oct;108(10):931-939. doi: 10.1016/j.bulcan.2021.04.017. Epub 2021 Jul 8.
7
Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.慢性肝脏疾病合并肝细胞癌患者低支链氨基酸/酪氨酸比值的简易临床预测因子：ALBI 评分作为营养预后标志物的效用。
Cancer Med. 2021 Jun;10(11):3584-3592. doi: 10.1002/cam4.3908. Epub 2021 May 7.
8
Prognostic Value of Myosteatosis and Albumin-Bilirubin Grade for Survival in Hepatocellular Carcinoma Post Chemoembolization.肌少脂变和白蛋白-胆红素分级对肝细胞癌化疗栓塞术后生存的预后价值
Cancers (Basel). 2024 Oct 17;16(20):3503. doi: 10.3390/cancers16203503.
9
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis.改良ALBI分级在肝细胞癌患者肝功能更详细评估中的验证：一项多中心分析
Liver Cancer. 2019 Mar;8(2):121-129. doi: 10.1159/000488778. Epub 2018 Jun 11.
10
A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade.通过改良白蛋白-胆红素（mALBI）分级对肝细胞癌患者的肝功能进行详细评估。
Am J Cancer Res. 2022 Jun 15;12(6):2711-2720. eCollection 2022.

引用本文的文献

1
Combination of modified albumin-bilirubin grade and platelet count to predict high-risk varices in patients with hepatocellular carcinoma.改良白蛋白-胆红素分级与血小板计数联合用于预测肝细胞癌患者的高危静脉曲张
PLoS One. 2025 Jul 17;20(7):e0327967. doi: 10.1371/journal.pone.0327967. eCollection 2025.
2
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).《肝细胞癌全程管理中国专家共识（2023年版）》
Liver Cancer. 2024 Oct 22;14(3):311-333. doi: 10.1159/000541622. eCollection 2025 Jun.
3
Systemic Therapy Combined with Locoregional Therapy in Intermediate-stage Hepatocellular Carcinoma.全身治疗联合局部区域治疗用于中期肝细胞癌
Interv Radiol (Higashimatsuyama). 2024 Dec 13;10:e20230035. doi: 10.22575/interventionalradiology.2023-0035. eCollection 2025 Mar 28.
4
Prognostic impact of albumin-bilirubin score in predicting the long-term survival of distal cholangiocarcinoma after radical surgery.白蛋白-胆红素评分对预测远端胆管癌根治术后长期生存的预后影响
World J Surg Oncol. 2025 Apr 24;23(1):160. doi: 10.1186/s12957-025-03813-2.
5
Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification.将ALBI分级与老年营养风险指数相结合可增强肝细胞癌风险分层。
Liver Cancer. 2024 Oct 5;14(2):193-210. doi: 10.1159/000541647. eCollection 2025 Apr.
6
Predicting Mortality and Cirrhosis-Related Complications with MELD3.0: A Multicenter Cohort Analysis.使用MELD 3.0预测死亡率和肝硬化相关并发症：一项多中心队列分析。
Gut Liver. 2025 May 15;19(3):427-437. doi: 10.5009/gnl240584. Epub 2025 Apr 11.
7
Lenvatinib plus Pembrolizumab Combined with Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.仑伐替尼联合帕博利珠单抗与经动脉化疗栓塞术治疗中期肝细胞癌
Liver Cancer. 2024 Dec 20;14(1):1-7. doi: 10.1159/000543245. eCollection 2025 Mar.
8
Validation of an albumin-indocyanine green-based China liver cancer staging system to evaluating resectable hepatocellular carcinoma patients and comparison with the Child-Pugh-based China liver cancer staging system.基于白蛋白-吲哚菁绿的中国肝癌分期系统对可切除肝细胞癌患者评估的验证及与基于Child-Pugh的中国肝癌分期系统的比较。
Front Oncol. 2025 Feb 20;15:1450333. doi: 10.3389/fonc.2025.1450333. eCollection 2025.
9
Characterization and Detection Strategy Exploration in Cryptogenic Hepatocellular Carcinoma: Insights From a Super-Aged Region in Japan.隐匿性肝细胞癌的特征及检测策略探索：来自日本一个超高龄地区的见解
Cancer Med. 2025 Jan;14(2):e70490. doi: 10.1002/cam4.70490.
10
Construction of a random survival forest model based on a machine learning algorithm to predict early recurrence after hepatectomy for adult hepatocellular carcinoma.基于机器学习算法构建随机生存森林模型以预测成人肝细胞癌肝切除术后的早期复发。
BMC Cancer. 2024 Dec 25;24(1):1575. doi: 10.1186/s12885-024-13366-4.

本文引用的文献

1
Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study.基于背景肝病病因的不可切除肝细胞癌患者应用仑伐替尼的疗效：多中心回顾性研究。
Sci Rep. 2021 Aug 17;11(1):16663. doi: 10.1038/s41598-021-96089-x.
2
Impact of modified albumin-bilirubin grade on survival in patients with HCC who received lenvatinib.改良的白蛋白-胆红素分级对接受仑伐替尼治疗的 HCC 患者生存的影响。
Sci Rep. 2021 Jul 14;11(1):14474. doi: 10.1038/s41598-021-93794-5.
3
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.日本肝细胞癌的管理：2021年更新版日本肝脏学会共识声明与建议
Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19.
4
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study.一项全国多中心研究中，接受乐伐替尼治疗的日本不可切除肝细胞癌患者的真实世界数据。
Cancers (Basel). 2021 May 26;13(11):2608. doi: 10.3390/cancers13112608.
5
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.预测肝细胞癌预后的EZ-ALBI评分
Liver Cancer. 2020 Dec;9(6):734-743. doi: 10.1159/000508971. Epub 2020 Oct 23.
6
Changes in Background Liver Function in Patients with Hepatocellular Carcinoma over 30 Years: Comparison of Child-Pugh Classification and Albumin Bilirubin Grade.30年间肝细胞癌患者肝脏基础功能的变化：Child-Pugh分级与白蛋白-胆红素分级的比较
Liver Cancer. 2020 Sep;9(5):518-528. doi: 10.1159/000507933. Epub 2020 Jul 16.
7
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.不可切除肝细胞癌患者接受仑伐替尼治疗后的进展后生存分析。
Oncology. 2020;98(11):787-797. doi: 10.1159/000509387. Epub 2020 Sep 3.
8
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.仑伐替尼治疗不可切除肝细胞癌的早期肝功能相对变化。
Oncology. 2019;97(6):334-340. doi: 10.1159/000502095. Epub 2019 Aug 29.
9
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study.基线ALBI分级对接受乐伐替尼治疗的肝细胞癌患者预后的影响：一项多中心研究
Cancers (Basel). 2019 Jul 7;11(7):952. doi: 10.3390/cancers11070952.
10
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis.改良ALBI分级在肝细胞癌患者肝功能更详细评估中的验证：一项多中心分析
Liver Cancer. 2019 Mar;8(2):121-129. doi: 10.1159/000488778. Epub 2018 Jun 11.